rizatriptan benzoate

Product NDC: 68462-468
Requested package NDC: 68462-468-06
11-digit product format: 684620468
Labeler code: 68462
Product ID: 68462-468_120ff156-182f-41d2-82a1-f9ff7fd412c6
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: rizatriptan benzoate
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: ORAL
Labeler: Glenmark Pharmaceuticals Inc., USA
Application: ANDA201914
Marketing category: ANDA
Marketing start: 2013-07-01
Substance: RIZATRIPTAN BENZOATE
Active strength: 10 mg/1
Pharmacologic classes: Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	68462-468	68462-468-06	D	Discontinued by firm		2026-11-12

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A201914-001	RIZATRIPTAN BENZOATE	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL			2013-07-01
A201914-002	RIZATRIPTAN BENZOATE	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL			2013-07-01

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A201914-001	RIZATRIPTAN BENZOATE	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A201914-002	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-01	`4b0b4de00fa7…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 60 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201914-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201914-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201914-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201914-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201914-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201914-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A201914-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A201914-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A201914-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A201914-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A201914-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A201914-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A201914-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A201914-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A201914-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A201914-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A201914-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A201914-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A201914-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A201914-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A201914-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A201914-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A201914-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A201914-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A201914-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A201914-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A201914-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A201914-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A201914-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A201914-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A201914-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A201914-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A201914-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A201914-002	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A201914-001	AB	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A201914-002	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A201914-001	AB	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A201914-002	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A201914-001	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A201914-002	AB	1	`ea1830bbd6c7…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: rizatriptan benzoate
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
RIZATRIPTAN BENZOATE	10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
WR978S7QHH	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
312837	Internal RxNorm lookup
312839	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4de33a24-db69-444a-b04d-c69ccba57ab2	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f2791553-0b76-42f4-8d49-af3eda072bfb	Product name	1	20251117
707ffe6e-db52-42b0-9a65-a0c00213f04f	Product name	1	20231006
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
8b537454-32b8-7e64-1395-258682782d07	Product name	5	20170424
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68462-468-06	rizatriptan benzoate	6 in 1 CARTON	TABLET, ORALLY DISINTEGRATING	6	13
68462-468-46	rizatriptan benzoate	1 in 1 POUCH	TABLET, ORALLY DISINTEGRATING	1	13
68462-468-46	rizatriptan benzoate	3 in 1 BOX	TABLET, ORALLY DISINTEGRATING	3	13
68462-468-74	rizatriptan benzoate	3 in 1 BOX	TABLET, ORALLY DISINTEGRATING	3	13
68462-468-74	rizatriptan benzoate	4 in 1 CARTON	TABLET, ORALLY DISINTEGRATING	4	13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68462-468-06	EA - Each	68462-468	8ec2e906-69a4-4884-ad4a-dc040669f2a9	1	2013-08-02
68462-468-46	EA - Each	68462-468	02cfb728-e4ae-47ee-a2ff-c3b363958877	1	2017-03-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
RIZATRIPTAN BENZOATE	ACTIVE INGREDIENT	WR978S7QHH	RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [GLENMARK PHARMACEUTICALS INC., USA]	5
RIZATRIPTAN	ACTIVE MOIETY	51086HBW8G	RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [GLENMARK PHARMACEUTICALS INC., USA]	5
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [GLENMARK PHARMACEUTICALS INC., USA]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [GLENMARK PHARMACEUTICALS INC., USA]	5
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [GLENMARK PHARMACEUTICALS INC., USA]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [GLENMARK PHARMACEUTICALS INC., USA]	5
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [GLENMARK PHARMACEUTICALS INC., USA]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [GLENMARK PHARMACEUTICALS INC., USA]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68462-468	RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [GLENMARK PHARMACEUTICALS INC., USA]	13	Current NDC, Legacy NDC, 5 package rows	20240104_4de33a24-db69-444a-b04d-c69ccba57ab2.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
WR978S7QHH	RIZATRIPTAN BENZOATE	145202-66-0	RIZATRIPTAN BENZOATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312837	rizatriptan benzoate 10 MG Disintegrating Oral Tablet	PSN	4de33a24-db69-444a-b04d-c69ccba57ab2	13
312839	rizatriptan benzoate 5 MG Disintegrating Oral Tablet	PSN	4de33a24-db69-444a-b04d-c69ccba57ab2	13
312837	rizatriptan 10 MG Disintegrating Oral Tablet	SCD	4de33a24-db69-444a-b04d-c69ccba57ab2	13
312839	rizatriptan 5 MG Disintegrating Oral Tablet	SCD	4de33a24-db69-444a-b04d-c69ccba57ab2	13
312837	rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Disintegrating Oral Tablet	SY	4de33a24-db69-444a-b04d-c69ccba57ab2	13
312839	rizatriptan 5 MG (as rizatriptan benzoate 7.265 MG) Disintegrating Oral Tablet	SY	4de33a24-db69-444a-b04d-c69ccba57ab2	13

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68462-468-06	68462046806	6 BOX in 1 CARTON (68462-468-06) > 3 POUCH in 1 BOX (68462-468-46) > 1 BLISTER PACK in 1 POUCH > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK	6 box	2013-07-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA \| Glenmark Pharmaceuticals Limited	2026-10-09	HUMAN PRESCRIPTION DRUG LABEL	14